P3 Health Partners insider entity sells 50,000 shares
Hudson Vegas Investment SPV, LLC, a 10% owner of P3 Health Partners Inc., reported three open-market sales of Class A Common Stock on 2026-08-10 totaling 50,000 shares.
Rhea-AI Filing Summary
Hudson Vegas Investment SPV, LLC, a 10% owner of P3 Health Partners Inc., reported three open-market sales of Class A Common Stock on 2026-08-10 totaling 50,000 shares. The sales used weighted average prices, with transaction price ranges from $13.00–$13.61, $16.00–$16.24, and $16.25–$17.24. Hudson Vegas Investment SPV, LLC is the direct beneficial owner; Hudson Vegas Investment Manager, LLC and Daniel Straus may be deemed to share voting and dispositive power but each disclaims beneficial ownership except to the extent of any pecuniary interest.
Positive
- None.
Negative
- None.
Insights
Analyzing...
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Class A Common Stock F1, F4 | 1,041 | $13.38 | $14K |
| Sale | Class A Common Stock F2, F4 | 19,074 | $16.05 | $306K |
| Sale | Class A Common Stock F3, F4 | 29,885 | $16.86 | $504K |
Footnotes (4)
- F1. The price reported is a weighted average price. Shares were sold in multiple transactions at prices ranging from $13.00 to $13.61, inclusive. The reporting persons undertake to provide to the Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
- F2. The price reported is a weighted average price. Shares were sold in multiple transactions at prices ranging from $16.00 to $16.24, inclusive. The reporting persons undertake to provide to the Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
- F3. The price reported is a weighted average price. Shares were sold in multiple transactions at prices ranging from $16.25 to $17.24, inclusive. The reporting persons undertake to provide to the Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
- F4. This statement is filed jointly by and on behalf of Hudson Vegas Investment SPV, LLC, Hudson Vegas Investment Manager, LLC and Daniel Straus. Hudson Vegas Investment SPV, LLC is the direct beneficial owner of the securities covered by this statement. Hudson Vegas Investment Manager, LLC and Daniel Straus each may be deemed to share voting and dispositive power over the shares of Class V Common Stock and P3 LLC Units which are held by Hudson Vegas Investment SPV, LLC. Each of Hudson Vegas Investment Manager, LLC and Daniel Straus disclaims beneficial ownership of any shares other than to the extent they may have a pecuniary interest therein.
Key Figures
Key Terms
weighted average price financial
disclaims beneficial ownership regulatory
pecuniary interest financial
voting and dispositive power regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider activity did P3 Health Partners Inc. (PIII) report on 2026-08-10?
Who is the direct beneficial owner in the PIII insider transactions?
Were the reported PIII insider sale prices single prices or averages?
Do Hudson Vegas Investment Manager, LLC and Daniel Straus claim full ownership of the PIII shares?
AI-generated analysis. How Rhea-AI works. Not financial advice.